Business Context and Reporting Period
Company: SANUWAVE Health, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: May 14, 2013
Reporting Period: Three months ended March 31, 2013
This filing announces the Company's financial results for the first quarter of fiscal 2013 and provides a business update. The report incorporates a press release and management's prepared remarks for a conference call held on May 15, 2013.
Key Financial Metrics
The provided text serves as a cover document referencing attached exhibits (Exhibit 99.1 and 99.2) for detailed data. The filing text itself does not provide specific numerical values for the following metrics:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Note: Specific financial figures are contained in the referenced press release and conference call remarks, which are not included in the input text.
Material Changes
The filing text does not explicitly detail material changes versus the prior comparable period. It only confirms the announcement of results for the three months ended March 31, 2013.
Guidance, Outlook, and Management Commentary
Management Commentary: The Company hosted a conference call on May 15, 2013, to discuss the Q1 2013 financial results and provide a business update. Prepared remarks for this call are attached as Exhibit 99.2.
Guidance and Risks: The filing text does not contain specific forward-looking guidance, risk factors, or contingencies. These details are expected to be found in the attached exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended March 31, 2013.
- Examine Exhibit 99.2 (Management Remarks) for year-over-year comparisons, margin analysis, and liquidity updates.
- Verify the Company's cash position and burn rate, as these are critical for early-stage health technology firms but are not listed in the 8-K summary text.
- Confirm if the "business update" mentioned in the conference call includes new product milestones or regulatory developments.